US · Basic Materials · Specialty Chemicals
EPS came in at 1.52 against a street estimate of 1.45 — a beat of 4.8%.
Analysts rate H B Fuller Company a strong buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $68.29.
CONFIDENT H.B. Fuller delivered better-than-expected Q3 growth and margins, maintained 2026 guidance, and highlighted pricing, restructuring, Quantum Leap savings and potential portfolio actions to support deleveraging. Q3 FY26 Asia Pacific was approximately flat including solar; HHC packaging growth helped offset weaker electronics and consumer conditions in China. Analysts focused on volume recovery, segment demand, pricing carryover, Quantum Leap savings, land-sale proceeds, shareholder pressure, and AMS performance. Management cited market uncertainty but remained constructive on pricing, restructuring, portfolio discipline, and deleveraging. 2026-09-24…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.44% |
| Vanguard Portfolio Management, LLC | 7.15% |
| State Street Corp | 5.31% |
| Dimensional Fund Advisors, Inc. | 5.31% |
| Vanguard Capital Management, LLC | 4.56% |
| Mairs & Power Inc | 4.52% |
| Neuberger Berman Group LLC | 4.44% |
| Kayne Anderson Rudnick Investment Management LLC | 3.72% |
| Document | Date |
|---|---|
| Company announcement · Q4 FY2026 HEADLINE NUMBERS • H.B. Fuller priced an offering of $850 million in aggregate principal amount of senior unsecured notes. • The notes carry a 7.625 | 2026-10-09 |
| Reg FD disclosure · Q4 FY2026 HEADLINE NUMBERS • H.B. Fuller commenced a private offering of $950 million of new senior unsecured notes due 2034. • The notes offering is intended | 2026-10-06 |
| Board / officer change · Q4 FY2026 OTHER NOTABLE POINTS • Ruth S. Kimmelshue resigned from H.B. Fuller’s Board of Directors effective immediately on September 23, 2026. • The company | 2026-09-28 |
| Quarterly report · Q3 FY2026 H.B. FULLER COMPANY – FORM 10-Q SUMMARY Quarter Ended August 29, 2026 --- HEADLINE NUMBERS • Net Revenue (9 months): $2,659,289K (vs. $2,578,801K p | 2026-09-24 |
| Results announced · Q4 FY2026 H.B. FULLER COMPANY – Q3 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q3 2026 Net Revenue: $938 million, up 5.2% year-on-year; organic revenue up 4.4% • | 2026-09-24 |
| Material agreement · Q3 FY2026 H.B. FULLER COMPANY (FUL) — FORM 8-K SUMMARY July 17, 2026 --- HEADLINE NUMBERS • Term A Loan refinanced: $420,000,000 principal amount with maturi | 2026-07-20 |
| Material agreement · Q3 FY2026 H.B. FULLER COMPANY – FORM 8-K SUMMARY HEADLINE NUMBERS • Acquisition Price: 285 pence in cash per share for Advanced Medical Solutions Group plc (A | 2026-06-26 |
| Quarterly report · Q2 FY2026 H.B. FULLER COMPANY - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net revenue Q2 2026: $950.3 million (up 5.8% vs. Q2 2025: $898.1 million) • Net revenu | 2026-06-25 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.24 / share ex-date Oct 15, 2026 · pay Oct 29, 2026 | 2026-10-15 |
| Dividend | $0.24 / share ex-date Jul 30, 2026 · pay Aug 13, 2026 | 2026-07-30 |
| Dividend | $0.24 / share ex-date Apr 30, 2026 · pay May 14, 2026 | 2026-04-30 |
| Dividend | $0.23 / share ex-date Feb 5, 2026 · pay Feb 19, 2026 | 2026-02-05 |
| Dividend | $0.23 / share ex-date Oct 16, 2025 · pay Oct 30, 2025 | 2025-10-16 |
| Announcement | Date |
|---|---|
| Debt offering priced to fund acquisition of Advanced Medical Solutions Group H.B. Fuller priced $850 million of new senior unsecured notes bearing 7.625% annual interest and maturing in 2034. The notes are expected to close around October 21, 2026, subject to customa | 2026-10-09 |
| Pro forma financial information presented for combined company following acquisition of AMS FUL disclosed unaudited pro forma financial information assuming its combination with AMS, a business that generated $313.0 million of revenue and $69.2 million of adjusted EBITDA for the 12 | 2026-10-06 |
| Recommended cash acquisition of Advanced Medical Solutions Group by H.B. Fuller H.B. Fuller Company announced it is acquiring Advanced Medical Solutions Group (AMS) for 285 pence per share in an all-cash deal, valuing the company at approximately £659 million (£715 mill | 2026-06-26 |
| Increases midpoint of full-year adjusted EBITDA and EPS guidance H.B. Fuller, an adhesives and specialty chemicals company, reported strong second quarter 2026 results that exceeded expectations. Key metrics: Net revenue reached $950 million (up 5.8% year | 2026-06-25 |
| Full-year revenue, adjusted EBITDA, and adjusted EPS guidance increased H.B. Fuller, an adhesives and specialty chemicals company, reported Q1 2026 results that demonstrate resilience despite challenging market conditions. Here are the key takeaways: **What Hap | 2026-03-26 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for H B Fuller Company — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.